tiprankstipranks
pc:alphy

Alphyn Biologics Inc

A clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics for severe and prevalent skin diseases. Its lead product candidate, Zabalafin Hydrogel, is being developed as a topical treatment for atopic dermatitis and the molluscum contagiosum virus.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$25M
Total Amount Raised$25M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$25M
Latest Funding Amount$25M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 12, 2025
Series B
$25.00M

Investors

Investor Name
Funding Round

Related News and Analysis